The impact of germline testing for hereditary cancer postdiagnosis.

The impact of germline testing for hereditary cancer postdiagnosis. Am J Manag Care. 2019 Aug;25(9 Spec No.):SP285-SP287 Authors: Owens K, Schlager L, Welcsh PL PMID: 31442012 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31442012?dopt=Abstract

Source: The American Journal of Managed Care - July 31, 2019 Category: Health Management Authors: Owens K, Schlager L, Welcsh PL Tags: Am J Manag Care Source Type: research

More News: Cancer | Cancer & Oncology | Health Management | Managed Care